Evidence map›Paper›PMID 37882106›Full record

ArticleAnnals of clinical and translational neurology2023

Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.

Akinori Nakamura, Tsuyoshi Matsumura, Katsuhisa Ogata, Madoka Mori-Yoshimura, Eri Takeshita, Koichi Kimura, Takahiro Kawashima, Yui Tomo, Hajime Arahata, Daigo Miyazaki and 18 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Annals of clinical and translational neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. X-Linked Muscular Dystrophy in a Cat with a Putative Variant in theAnimals : an open access journal from MDPI · 2026
    Article
  6. Respiratory function in Becker muscular dystrophy: a comprehensive longitudinal study.Journal of neurology, neurosurgery, and psychiatry · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 1 country.

Akinori NakamuraDepartment of Neurology, NHO Matsumoto Medical Center, Matsumoto, Japan.ORCID 0000-0001-8801-6688
Tsuyoshi MatsumuraDepartment of Neurology, NHO Osaka Toneyama Medical Center, Toyonaka, Japan.
Katsuhisa OgataDepartment of Neurology, NHO Higashisaitama National Hospital, Hasuda, Japan.
Madoka Mori-YoshimuraDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Eri TakeshitaDepartment of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.
Koichi KimuraDepartment of Laboratory Medicine/Cardiology, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan.
Takahiro KawashimaDepartment of Information Medicine, National Center of Neurology and Psychiatry, National Institute of Neuroscience, Kodaira, Japan.
Yui TomoDepartment of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Kodaira, Japan.
Hajime ArahataDepartment of Neurology, Neuro-Muscular Center, NHO Omuta National Hospital, Omuta, Japan.
Daigo MiyazakiDepartment of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
Yasuhiro TakeshimaDepartment of Pediatrics, Hyogo Medical University School of Medicine, Nishinomiya, Japan.
Toshiaki TakahashiDepartment of Neurology, NHO Sendai-Nishitaga Hospital, Sendai, Japan.
Keiko IshigakiDepartment of Pediatrics, Tokyo Women's Medical University School of Medicine, Shinjuku-ku, Japan.
Satoshi KuruDepartment of Neurology, NHO Suzuka National Hospital, Suzuka, Japan.
Akiko WakisakaDepartment of Pediatrics, NHO Iou National Hospital, Kanazawa, Japan.
Hiroyuki AwanoResearch Initiative Center, Organization for Research Initiative and Promotion, Tottori University, Yonago, Japan.
Michinori FunatoDepartment of Pediatric Neurology, NHO Nagara Medical Center, Nagara, Japan.
Tatsuharu SatoDepartment of Pediatrics, Nagasaki University Hospital, Nagasaki, Japan.
Yoshiaki SaitoDepartment of Pediatrics, National Rehabilitation Center for Children with Disabilities, Itabashi, Japan.
Hiroto TakadaDepartment of Neurology, NHO Aomori National Hospital, Aomori, Japan.
Kazuma SugieDepartment of Neurology, Nara Medical University School of Medicine, Kashihara, Japan.
Michio KobayashiDepartment of Neurology, NHO Akita National Hospital, Yurihonjo, Japan.
Shiro OzasaDepartment of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan.
Tatsuya FujiiDepartment of Pediatrics, Shiga Medical Center for Children, Moriyama, Japan.
Yoshihiro MaegakiDivision of Child Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Yonago, Japan.
Hideki OiDepartment of Clinical Data Science, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Kodaira, Japan.
Hisateru TachimoriDepartment of Information Medicine, National Center of Neurology and Psychiatry, National Institute of Neuroscience, Kodaira, Japan.
Hirofumi KomakiDepartment of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan.ORCID 0000-0002-0659-1417
National Center of Neurology and Psychiatry · JPTottori University · JPAomori Rosai Hospital · JPHakodate National Hospital · JPHyogo Medical University · JPKanazawa Hospital · JPKeio University · JPKumamoto University Hospital · JPMatsumoto University · JPNagara Medical Center · JPNagasaki University Hospital · JPNara Medical University · JPNational Institute of Technology, Suzuka College · JPNational Rehabilitation Center for Persons with Disabilities · JPOmuta hospital · JPSangi (Japan) · JPSendai Nishitaga National Hospital · JPShiga Medical Center for Children · JPShinshu University · JPThe University of Tokyo · JP

Funding

Intramural Research Grant for Neurological and Psychiatric Disorder from the National Research Center for Neurology and Psychiatry 26-6Japan Agency for Medical Research and Development JP20ek0109357Japan Agency for Medical Research and Development JP21ek0109533Ministry of Health, Labour and Welfare and Science and Technology H30-nanchitou (Nan)-Ippan-005
6 · The paper itself

Abstract

objectiveBecker muscular dystrophy (BMD) is a milder variant of Duchenne muscular dystrophy (DMD), a lethal X-linked muscular disorder. Here, we aim to investigat the clinical involvement of skeletal, respiratory, cardiac, and central nervous systems in patients with BMD, as well as genotype-phenotype relationships.

methodsThis nationwide cohort study investigated the clinical manifestations and genotype-phenotype relationships in 225 patients with BMD having in-frame deletion from 22 medical centers. The primary outcome was to elucidate the association of genotype with skeletal muscle, respiratory, cardiac, and central nervous system disorders. Descriptive statistics were used to analyze the data.

resultsThe average age of the subjects was 31.5 (range, 1-81) years. Initial symptoms of BMD were muscular (60%), followed by asymptomatic hypercreatine kinasemia (32.4%) and central nervous system disorders (5.3%). Gait disturbance was observed in 53.8% of patients and the average age at wheelchair introduction was 36.5 years. The ventilator introduction rate was 6.7% at an average age of 36.6 years. More than 30% of patients had an abnormal electrocardiogram and approximately 15% had heart failure symptoms. Cardiac function on echocardiography varied significantly among the patients. The frequencies of seizures and intellectual/developmental disability were 8.0% and 16.9%, respectively. Exon 45-47deletion (del) was the most common (22.6%), followed by exon 45-48del (13.1%). Patients with exon 45-49del patients demonstrated severe skeletal muscle damage. Patients with exon 45-47del and exon 45-55del patients did not require ventilator use.

interpretationThe study provides important prognostic information for patients and clinicians to establish therapy plans and to implement preventative medicine.

Indexed as

Central Nervous System DiseasesHeart DiseasesIntellectual DisabilityMuscular Dystrophy, DuchenneAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCohort StudiesDystrophinGenotypeHumansInfantMiddle AgedDystrophin

Identifiers

PMID37882106
PMCPMC10723226
OpenAlexW4387950774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.